Bayer and Janssen Slap Lawsuit on Taro Over Alleged Xarelto Patent Infringement
In a recent development in the pharmaceutical sector, industry giants Bayer and Janssen have initiated a lawsuit against their competitor, Taro. They allege that Taro has violated a patent related to a drug that assists in the prevention of significant cardiovascular incidents. Such an action escalates the ongoing battle concerning whether Taro’s generic alternative stands…